Heidenreich PA et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 145(18):e895–e1032

PubMed  Google Scholar 

Čerlinskaitė K et al (2021) Readmission following both cardiac and non-cardiac acute dyspnoea is associated with a striking risk of death. ESC Heart Fail 8(4):2473–2484

Article  PubMed  PubMed Central  Google Scholar 

Tsao CW et al (2023) Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147(8):e93–e621

Article  PubMed  Google Scholar 

Goldgrab D et al (2019) Updates in heart failure 30-day readmission prevention. Heart Fail Rev 24(2):177–187

Article  PubMed  CAS  Google Scholar 

Greene SJ et al (2015) The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol 12(4):220–229

Article  PubMed  Google Scholar 

Gheorghiade M et al (2012) A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev 17(3):485–509

Article  PubMed  Google Scholar 

McDonagh TA et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  PubMed  CAS  Google Scholar 

Greene SJ et al (2018) Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol 72(4):351–366

Article  PubMed  Google Scholar 

Schrage B et al (2021) Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure. Heart 107(3):229–236

Article  PubMed  Google Scholar 

Savarese G et al (2018) Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail 20(9):1326–1334

Article  PubMed  CAS  Google Scholar 

Rosano GMC et al (2021) Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23(6):872–881

Article  PubMed  Google Scholar 

Saxena FE et al (2022) Association of early physician follow-up with readmission among patients hospitalized for acute myocardial infarction, congestive heart failure, or chronic obstructive pulmonary disease. JAMA Netw Open 5(7):e2222056

Article  PubMed  PubMed Central  Google Scholar 

Balasubramanian I, Malhotra C (2024) Can timely outpatient visits reduce readmissions and mortality among heart failure patients? J Gen Intern Med 39(13):2478–2486

Article  PubMed  Google Scholar 

Matsukawa R et al (2021) Early follow-up at outpatient care after discharge improves long-term heart failure readmission rate and prognosis. ESC Heart Fail 8(4):3002–3013

Article  PubMed  PubMed Central  Google Scholar 

Avaldi VM et al (2017) Effect of cardiologist care on 6-month outcomes in patients discharged with heart failure: results from an observational study based on administrative data. BMJ Open 7(11):e018243

Article  PubMed  PubMed Central  Google Scholar 

McAlister FA et al (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 44(4):810–819

PubMed  Google Scholar 

Hanna TP et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087

Article  PubMed  Google Scholar 

Kimmoun A et al (2019) Safety, tolerability and efficacy of rapid optimization, helped by NT-proBNP and GDF-15, of heart failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study. Eur J Heart Fail 21(11):1459–1467

Article  PubMed  CAS  Google Scholar 

Heidenreich PA et al (2022) 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263–e421

Article  PubMed  Google Scholar 

Mebazaa A et al (2022) Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400(10367):1938–1952

Article  PubMed  CAS  Google Scholar 

McMurray JJ et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004

Article  PubMed  Google Scholar 

Docherty KF et al (2020) Sacubitril/valsartan: neprilysin inhibition 5 years after PARADIGM-HF. JACC Heart Fail 8(10):800–810

Article  PubMed  PubMed Central  Google Scholar 

Investigators S (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England J Med 325(5):293–302

Article  Google Scholar 

Group MHS (1999) Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in-congestive heart failure (MERIT-HF). The Lancet 353(9169):2001–2007

Article  Google Scholar 

Pitt B et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10):709–717

Article  PubMed  CAS  Google Scholar 

Packer M et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413–1424

Article  PubMed  CAS  Google Scholar 

Komajda M et al (2017) Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail 19(11):1414–1423

Article  PubMed  CAS  Google Scholar 

Komajda M et al (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26(16):1653–1659

Article  PubMed  Google Scholar 

Greene SJ et al (2022) Comparative effectiveness of dosing of medical therapy for heart failure: from the CHAMP-HF registry. J Card Fail 28(3):370–384

Article  PubMed  Google Scholar 

Teng TK et al (2018) Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Glob Health 6(9):e1008–e1018

Article  PubMed  Google Scholar 

Sepehrvand N et al (2023) Time to triple therapy in patients with de novo heart failure with reduced ejection fraction: a population-based study. J Card Fail 29(5):719–729

Article  PubMed  Google Scholar 

Tromp J et al (2022) A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. JACC: Heart Failure 10(2):73–84

PubMed  CAS  Google Scholar 

Averbuch T, Greene SJ, Van Spall HGC (2023) Guideline-recommended therapy following hospitalization for heart failure: understanding the gaps, navigating the barriers. JACC Heart Fail 11(10):1333–1336

Article  PubMed  CAS  Google Scholar 

Averbuch T et al (2023) Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries. ESC Heart Fail 10(5):3152–3163

Article  PubMed  PubMed Central  Google Scholar 

Packer M, McMurray JJV (2021) Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction. Eur J Heart Fail 23(6):882–894

Article